Citation Impact
Citing Papers
Molecularly imprinted polymers for sample preparation: A review
2010 Standout
Current role of LC-MS in therapeutic drug monitoring
2007
Repurposing clinically approved cephalosporins for tuberculosis therapy
2016
Pharmacokinetic-Pharmacodynamic and Dose-Response Relationships of Antituberculosis Drugs: Recommendations and Standards for Industry and Academia
2015
Molecularly imprinted polymer for analysis of zidovudine and stavudine in human serum by liquid chromatography–mass spectrometry
2009
New materials in sorptive extraction techniques for polar compounds
2006
Advances in the development of new tuberculosis drugs and treatment regimens
2013
Comparison of antibiotic resistant Escherichia coli obtained from drinking water sources in northern Tanzania: a cross-sectional study
2016
Antiretroviral Treatment of Adult HIV Infection
2012 Standout
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Immunosuppressant Pharmacokinetics and Dosing Modifications in HIV-1 Infected Liver and Kidney Transplant Recipients
2007
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
2016 Standout
Drug Susceptibility Testing of Nontuberculous Mycobacteria
2014
Decontamination and disinfection of water by solar photocatalysis: Recent overview and trends
2009 Standout
Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Sources: Potential Public Health Implications
2018 Standout
Visualization of mycobacterial membrane dynamics in live cells
2017 StandoutNobel
Quality Assurance Program for Clinical Measurement of Antiretrovirals: AIDS Clinical Trials Group Proficiency Testing Program for Pediatric and Adult Pharmacology Laboratories
2004
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
Markers of gut dysfunction do not explain low rifampicin bioavailability in HIV-associated TB
2017 StandoutNobel
A Fluorogenic Trehalose Probe for Tracking Phagocytosed Mycobacterium tuberculosis
2020 StandoutNobel
Acute Modulation of Mycobacterial Cell Envelope Biogenesis by Front‐Line Tuberculosis Drugs
2018 StandoutNobel
Works of R.E. Aarnoutse being referenced
Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment?
2011
Pharmacokinetics, food intake requirements and tolerability of once‐daily combinations of nelfinavir and low‐dose ritonavir in healthy volunteers
2003
Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography
2004
Sale of fluoroquinolones in northern Tanzania: a potential threat for fluoroquinolone use in tuberculosis treatment
2009
High-performance liquid chromatography of HIV protease inhibitors in human biological matrices
2001